Brian Hansen Named EVP and Chief Commercial Officer, Lori Gildea
Named VP, Sales
SAN DIEGO--(BUSINESS WIRE)--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the t:slim®, t:slim G4™ and t:flex® Insulin Pumps, today
announced that Brian Hansen has joined the Company as Executive Vice
President and Chief Commercial Officer, and Lori Gildea as Vice
President, Sales. Mr. Hansen is responsible for managing the strategic
direction of the commercial organization with an emphasis on customer
satisfaction, and functional responsibility for sales, marketing and
customer service. Ms. Gildea is leading the Company's sales and sales
support efforts, which focus on offering a portfolio of insulin pumps to
meet the diverse needs of the diabetes community.
"It's an exciting time for our commercial organization as we enter 2016
with three insulin pump offerings, a #1 customer service rating, and an
expanding sales and clinical team," said Kim Blickenstaff, president and
CEO, Tandem Diabetes Care. "Brian and Lori have dynamic leadership
skills that will leverage this momentum to further develop our
commercial organization as we enter our next phase of growth."
Prior to joining Tandem, Mr. Hansen was Chief Commercial Officer at
Adaptive Biotechnologies Corporation. Before that, he held executive and
senior-level positions at Genoptix (a Novartis-owned company), Gen-Probe
(acquired by Hologic in 2012) and Fischer Scientific. Mr. Hansen
received an MBA from the School of Business at San Diego State
University and a BS in Business Administration from the University of
Missouri - Columbia.
Before joining Tandem, Ms. Gildea was Area Vice President of Sales at
Iroko Pharmaceuticals. Prior to that, she served in various sales
leadership positions at Valeant Pharmaceuticals, AstraZeneca and Sanofi.
She began her career at Bausch + Lomb. Ms. Gildea holds an MBA from
Villanova University and a BS in Business Administration (Marketing)
from Millersville University of Pennsylvania.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company with an innovative, user-centric and
integrated approach to the design, development and commercialization of
products for people with diabetes who use insulin. The Company
manufactures and sells the t:slim® Insulin Pump, the slimmest and
smallest durable insulin pump currently on the market; the t:flex®
Insulin Pump, the first pump designed for people with greater insulin
requirements; and the t:slim G4™ Insulin Pump, the first CGM-enabled
pump with touch-screen simplicity. Tandem is based in San Diego,
California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim,
#tslimG4, #tflex, #tconnect and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/TandemDiabetes.
t:slim, t:flex, Micro-Delivery and Tandem Diabetes Care are registered
trademarks, and t:slim G4 and t:simulator are trademarks of Tandem
Diabetes Care, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160202005639/en/
For Tandem Diabetes Care
Media Contact:
Steve
Sabicer, 714-907-6264
ssabicer@thesabicergroup.com
or
Investor
Contact:
Susan Morrison, 858-366-6900 x7005
smorrison@tandemdiabetes.com
Source: Tandem Diabetes Care, Inc.
News Provided by Acquire Media
